Mr. Donal Moriarty:

It is not a panacea. We have described it as an initial step, which is positive in that it provides a roadmap for the removal of the 14-day restriction on movements. Our view is that it needs to evolve and that there is a need to establish rapid, affordable antigen testing as both the testing standard and the testing solution on a screening basis. There is a further need to evolve to a limited form of random, rapid testing for passengers from higher-risk orange Covid countries and regions, and a pre-departure rapid test for those from red countries. We believe that is the solution. That testing standard needs to be on the basis of an antigen test.